title: 3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer.
abstract: It should be noted that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is a protein encoded by the PDPK1 gene, which plays a key role in the signaling pathways activated by several growth factors and hormones. PDK1 is a crucial kinase that functions downstream of phosphoinositide 3-kinase activation and activates members of the AGC family of protein kinases, such as protein kinase B (Akt), protein kinase C (PKC), p70 ribosomal protein S6 kinases, and serum glucocorticoid-dependent kinase, by phosphorylating serine/threonine residues in the activation loop. AGC kinases are known to play crucial roles in regulating physiological processes relevant to metabolism, growth, proliferation, and survival. Changes in the expression and activity of PDK1 and several AGC kinases have been linked to human diseases including cancer. Recent data have revealed that the alteration of PDK1 is a critical component of oncogenic phosphoinositide 3-kinase signaling in breast cancer, suggesting that inhibition of PDK1 can inhibit breast cancer progression. Indeed, PDK1 is highly expressed in a majority of human breast cancer cell lines and both PDK1 protein and messenger ribonucleic acid are overexpressed in a majority of human breast cancers. Furthermore, overexpression of PDK1 is sufficient to transform mammary epithelial cells. PDK1 plays an essential role in regulating cell migration, especially in the context of phosphatase and tensin homologue deficiency. More importantly, downregulation of PDK1 levels inhibits migration and experimental metastasis of human breast cancer cells. Thus, targeting PDK1 may be a valuable anticancer strategy that may improve the efficacy of chemotherapeutic strategies in breast cancer patients. In this review, we summarize the evidence that has been reported to support the idea that PDK1 may be a key target in breast cancer management.
authors.affiliation: Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Inositide Signallling Group, London, UK.
authors.forename: Chanse
authors.initials: C
authors.lastname: Fyffe
authors.forename: Marco
authors.initials: M
authors.lastname: Falasca
keywords: 3-phosphoinositide-dependent protein kinase-1; AGC protein kinases; breast cancer therapy; cell signaling; oncogenic kinase; phosphoinositide 3-kinase
references.citation: Nature. 1995 Aug 17;376(6541):599-602
references.pmid: 7637810
references.citation: Nature. 1993 May 27;363(6427):309-10
references.pmid: 8497315
references.citation: Transl Oncol. 2012 Dec;5(6):453-60
references.pmid: 23401739
references.citation: Biochem J. 2012 May 1;443(3):587-601
references.pmid: 22507127
references.citation: Clin Cancer Res. 2010 Oct 15;16(20):4928-37
references.pmid: 20876794
references.citation: J Biol Chem. 2011 Feb 25;286(8):6433-48
references.pmid: 21118801
references.citation: Blood. 2011 Sep 29;118(13):3603-12
references.pmid: 21803855
references.citation: Int J Cancer. 2012 Jun 1;130(11):2505-13
references.pmid: 21796621
references.citation: J Cell Sci. 2012 Jul 1;125(Pt 13):3153-63
references.pmid: 22454520
references.citation: J Natl Compr Canc Netw. 2013 Jun 1;11(6):670-8
references.pmid: 23744866
references.citation: Curr Med Chem. 2011;18(18):2763-9
references.pmid: 21568903
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1289-94
references.pmid: 16432180
references.citation: Front Pharmacol. 2012 Jun 27;3:113
references.pmid: 22754526
references.citation: Nat Rev Mol Cell Biol. 2010 Jan;11(1):9-22
references.pmid: 20027184
references.citation: Cancer Cell. 2009 Jul 7;16(1):21-32
references.pmid: 19573809
references.citation: Br J Cancer. 2005 Dec 12;93(12):1372-81
references.pmid: 16288304
references.citation: BMC Cancer. 2006 Mar 21;6:77
references.pmid: 16551362
references.citation: Science. 1997 Mar 28;275(5308):1943-7
references.pmid: 9072974
references.citation: Br J Cancer. 2007 Nov 19;97(10):1416-24
references.pmid: 17940511
references.citation: Cancer Cell. 2013 Mar 18;23(3):406-20
references.pmid: 23453624
references.citation: Biochem Pharmacol. 2013 May 15;85(10):1454-62
references.pmid: 23500535
references.citation: J Med Chem. 2013 Apr 11;56(7):2726-37
references.pmid: 23448267
references.citation: Science. 1998 Jan 30;279(5351):710-4
references.pmid: 9445477
references.citation: Cancer Biol Ther. 2004 Aug;3(8):772-5
references.pmid: 15254419
references.citation: J Biol Chem. 1994 Feb 4;269(5):3568-73
references.pmid: 8106400
references.citation: Curr Top Microbiol Immunol. 2010;347:21-41
references.pmid: 20535651
references.citation: Breast Cancer (Auckl). 2013;7:7-22
references.pmid: 23492649
references.citation: Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2569-74
references.pmid: 23359693
references.citation: Br J Cancer. 2013 Jan 15;108(1):170-8
references.pmid: 23321518
references.citation: Nat Cell Biol. 2008 Feb;10(2):127-37
references.pmid: 18204440
references.citation: Science. 2002 May 31;296(5573):1655-7
references.pmid: 12040186
references.citation: Br J Cancer. 2010 Jan 5;102(1):104-14
references.pmid: 20051961
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7
references.pmid: 15647370
references.citation: Expert Opin Investig Drugs. 2012 Jan;21(1):15-22
references.pmid: 22112004
references.citation: Mol Cancer Res. 2009 Jun;7(6):944-54
references.pmid: 19531564
references.citation: Nat Rev Mol Cell Biol. 2010 May;11(5):329-41
references.pmid: 20379207
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7415-9
references.pmid: 8052599
references.citation: Biochem J. 1999 Feb 1;337 ( Pt 3):575-83
references.pmid: 9895304
references.citation: Nat Genet. 1998 Aug;19(4):348-55
references.pmid: 9697695
references.citation: Mol Cancer Ther. 2012 Jun;11(6):1236-46
references.pmid: 22491800
references.citation: Carcinogenesis. 2012 Jul;33(7):1270-6
references.pmid: 22510280
references.citation: Cancer Res. 2005 Dec 1;65(23):10669-73
references.pmid: 16322209
references.citation: Nat Rev Clin Oncol. 2010 Dec;7(12):669-70
references.pmid: 21116236
references.citation: Nature. 1997 Feb 6;385(6616):544-8
references.pmid: 9020362
references.citation: Cancer Res. 2013 Jun 1;73(11):3248-61
references.pmid: 23580570
references.citation: Clin Cancer Res. 2006 Mar 1;12(5):1441-6
references.pmid: 16533766
references.citation: Science. 2004 Apr 23;304(5670):554
references.pmid: 15016963
references.citation: Science. 1997 Jan 31;275(5300):661-5
references.pmid: 9005851
references.citation: Cancer Res. 2011 Apr 1;71(7):2622-31
references.pmid: 21310824
references.citation: J Exp Med. 2012 Dec 17;209(13):2441-53
references.pmid: 23183047
references.citation: Curr Biol. 2005 Oct 25;15(20):1839-46
references.pmid: 16243031
references.citation: Blood. 2011 Jan 13;117(2):591-4
references.pmid: 20959606
references.citation: Curr Pharm Des. 2010;16(12):1410-6
references.pmid: 20166984
references.citation: Neoplasia. 2012 Aug;14(8):719-31
references.pmid: 22952425
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8
references.pmid: 9990064
references.citation: Curr Biol. 1997 Apr 1;7(4):261-9
references.pmid: 9094314
references.citation: Semin Cell Dev Biol. 2004 Apr;15(2):161-70
references.pmid: 15209375
references.citation: Cancer Res. 2009 Aug 1;69(15):6299-306
references.pmid: 19602588
references.citation: Cell. 2007 Jun 29;129(7):1261-74
references.pmid: 17604717
references.citation: Nature. 1994 Sep 8;371(6493):168-70
references.pmid: 8072546
references.citation: Sci Signal. 2010 Oct 26;3(145):ra78
references.pmid: 20978239
references.citation: Blood. 2007 May 15;109(10):4461-9
references.pmid: 17255356
references.citation: Biochem J. 2011 Jan 15;433(2):357-69
references.pmid: 21087210
references.citation: Trends Cell Biol. 1997 Jun;7(6):237-42
references.pmid: 17708952
references.citation: Cancer Cell. 2010 Nov 16;18(5):459-71
references.pmid: 21075311
references.citation: Breast Cancer Res. 2011 Sep 20;13(5):R90
references.pmid: 21542898
references.citation: PLoS One. 2012;7(10):e48402
references.pmid: 23119004
references.citation: Blood. 2010 Sep 23;116(12):2078-88
references.pmid: 20522708
references.citation: J Exp Med. 2009 Oct 26;206(11):2441-54
references.pmid: 19808258
references.citation: Nat Genet. 1997 Apr;15(4):356-62
references.pmid: 9090379
references.citation: Nat Rev Mol Cell Biol. 2012 Apr 04;13(5):283-96
references.pmid: 22473468
references.citation: Biochem J. 2009 Jan 1;417(1):361-70
references.pmid: 18976239
references.citation: ChemMedChem. 2008 Dec;3(12):1810-38
references.pmid: 18972468
references.citation: Curr Pharm Des. 2013;19(4):680-6
references.pmid: 23016860
references.citation: Curr Biol. 1994 May 1;4(5):385-93
references.pmid: 7922352
references.citation: J Biol Chem. 2003 Oct 31;278(44):42913-9
references.pmid: 12923190
references.citation: Blood. 2012 Feb 23;119(8):1897-900
references.pmid: 22210877
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3627-32
references.pmid: 9108028
references.citation: Biochem J. 2012 Dec 1;448(2):285-95
references.pmid: 23030823